PL2213669T3 - Krystaliczna pochodna kwasu imidazolo-5-karboksylowego - Google Patents

Krystaliczna pochodna kwasu imidazolo-5-karboksylowego

Info

Publication number
PL2213669T3
PL2213669T3 PL08838798T PL08838798T PL2213669T3 PL 2213669 T3 PL2213669 T3 PL 2213669T3 PL 08838798 T PL08838798 T PL 08838798T PL 08838798 T PL08838798 T PL 08838798T PL 2213669 T3 PL2213669 T3 PL 2213669T3
Authority
PL
Poland
Prior art keywords
imidazol
crystalline
carboxylic acid
acid derivate
derivate
Prior art date
Application number
PL08838798T
Other languages
English (en)
Inventor
Jianhui Guo
Dong An
Original Assignee
Shenzhen Salubris Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Salubris Pharm Co Ltd filed Critical Shenzhen Salubris Pharm Co Ltd
Publication of PL2213669T3 publication Critical patent/PL2213669T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL08838798T 2007-10-11 2008-10-10 Krystaliczna pochodna kwasu imidazolo-5-karboksylowego PL2213669T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2007100941310A CN101407511B (zh) 2007-10-11 2007-10-11 一种结晶型的咪唑-5-羧酸衍生物
EP08838798.0A EP2213669B1 (en) 2007-10-11 2008-10-10 Crystalline imidazol-5-carboxylic acid derivate
PCT/CN2008/001715 WO2009049495A1 (en) 2007-10-11 2008-10-10 Crystalline imidazol-5-carboxylic acid derivate

Publications (1)

Publication Number Publication Date
PL2213669T3 true PL2213669T3 (pl) 2015-12-31

Family

ID=40566990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08838798T PL2213669T3 (pl) 2007-10-11 2008-10-10 Krystaliczna pochodna kwasu imidazolo-5-karboksylowego

Country Status (6)

Country Link
US (1) US8178569B2 (pl)
EP (1) EP2213669B1 (pl)
JP (1) JP5303765B2 (pl)
CN (1) CN101407511B (pl)
PL (1) PL2213669T3 (pl)
WO (1) WO2009049495A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
CN101317842A (zh) * 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
CN104610232B (zh) * 2013-11-01 2019-09-20 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
CN103965171A (zh) * 2014-04-30 2014-08-06 上海艾力斯医药科技有限公司 一种阿利沙坦酯的制备方法
CN106188012B (zh) * 2014-06-20 2018-11-30 深圳信立泰药业股份有限公司 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物
CN115947722B (zh) * 2017-10-24 2024-04-02 深圳信立泰药业股份有限公司 阿利沙坦酯钠盐晶型及含有所述钠盐晶型的药物组合物
CN114163391B (zh) * 2021-12-14 2024-02-02 迪嘉药业集团股份有限公司 一种坎地沙坦中间体及坎地沙坦的制备方法
CN119371408B (zh) * 2024-12-27 2025-04-22 安徽艾立德制药有限公司 一种无定形的阿利沙坦酯及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
DK1653950T3 (da) * 2003-07-31 2008-05-26 Nicox Sa Nitrooxyderivater af Losartan, Valsatan, Candesartan, Telmisartan, Eprosartan og Olmesartan som angiotensin II-receptorblokkere til behandling af cardiovaskulære sygdomme
CN101024643A (zh) * 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
EP2103610B1 (en) 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof

Also Published As

Publication number Publication date
EP2213669A9 (en) 2011-05-04
CN101407511B (zh) 2013-01-09
WO2009049495A1 (en) 2009-04-23
EP2213669B1 (en) 2015-07-29
EP2213669A4 (en) 2011-02-16
US8178569B2 (en) 2012-05-15
US20100292286A1 (en) 2010-11-18
CN101407511A (zh) 2009-04-15
JP5303765B2 (ja) 2013-10-02
EP2213669A1 (en) 2010-08-04
JP2011500515A (ja) 2011-01-06

Similar Documents

Publication Publication Date Title
PL2264009T3 (pl) Związek stanowiący kwas pirydyloaminooctowy
SI2192109T1 (sl) Biciklični aminokislinski derivati
GB0819182D0 (en) Crystalline forms
GB0818033D0 (en) Novel compound
EP2216330A4 (en) OXADIAZOLIDINDIONVERBINDUNG
GB0706072D0 (en) Compound
IL206102A0 (en) Crystalline (r)-2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-
ZA201000869B (en) Phenylacetic acid compound
GB0804989D0 (en) Compound
GB0803494D0 (en) Compound
IL206524A0 (en) 4-dimethylminobutyric acid derivatives
IL207035A0 (en) Benzylpiperizine compound
PL2173710T3 (pl) Nowa postać krystaliczna
GB0823316D0 (en) Compound
HU0800755D0 (en) Novel crystalline forms
IL213288A0 (en) Crystalline forms
GB0817164D0 (en) Crystalline forms
GB0820915D0 (en) Compound
GB0815806D0 (en) Compound
GB0812580D0 (en) Compound
GB0806005D0 (en) Compound
GB0802193D0 (en) Compound
GB0822635D0 (en) Compound
GB0820916D0 (en) Compound
GB0802227D0 (en) Compound